Is this a good combo to start?
Jan 2, 2008
My Dr. has recommended viramune and truvada. Because of my concerns with the psychological effects of sustiva he recommended viramune and truvada. Is this as effective as the once a day pill and a good choice for first timers who have never been on meds before? Thanks.
Response from Dr. Young
Thanks for your post.
The regimen that your doctor has recommended is viewed by national and international treatment guidelines as an alternative one (compared to other "preferred" or recommended regimens). Certainly, nevirapine (Viramune) shouldn't be initiated by persons with higher CD4 counts (>250 for women, >400 for men) because of increased risk of serious liver toxicity; there are unsettled questions about the relative potency of nevirapine compared with efavirenz (Sustiva) or any of the boosted protease inhibitors recommended by guidelines (atazanavir, fosamprenavir or lopinavir).
Conservatively speaking, I generally have not been starting patients on nevirapine, but rather have in large part initiated my patients on the once-daily ritonavir (Novir) boosted PIs, mostly fosamprenavir (Lexiva) and atazanavir (Reyataz).
Hope this helps, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Why Do I Have Recurrent Bacterial Vaginosis?
- Why Are Genital Warts More Prevalent In Homosexual Men?
- What Systems Of The Body Do Shingles Affect?
- What Percent Of People Have Herpes?
- What Is The Difference Between Razor Burn And Herpes On The Vagina?
- What Does Chlamydia Discharge In Women Look Like?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.